Mednax Inc (MD)
Current ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Total current assets | US$ in thousands | 639,607 | 483,454 | 334,750 | 740,849 | 1,549,350 |
| Total current liabilities | US$ in thousands | 434,110 | 388,946 | 374,225 | 394,118 | 423,157 |
| Current ratio | 1.47 | 1.24 | 0.89 | 1.88 | 3.66 |
December 31, 2024 calculation
Current ratio = Total current assets ÷ Total current liabilities
= $639,607K ÷ $434,110K
= 1.47
The current ratio for Mednax Inc has shown a declining trend over the years. As of December 31, 2020, the current ratio was 3.66, indicating a strong liquidity position with ample current assets to cover current liabilities. However, by the end of December 31, 2022, the current ratio dropped to 0.89, implying a potential liquidity strain as current assets may not be sufficient to meet short-term obligations.
Subsequently, there was a slight improvement in the current ratio to 1.24 as of December 31, 2023, suggesting a partial recovery in liquidity. By the end of December 31, 2024, the current ratio further increased to 1.47, indicating a better ability to meet current obligations with available current assets.
Overall, the decreasing trend in the current ratio until 2022 raised concerns about the company's short-term liquidity, but the subsequent rebound in the ratio in the following years suggests efforts to strengthen liquidity management. Monitoring this ratio will be essential to assess Mednax Inc's ability to meet its short-term financial obligations effectively.
Peer comparison
Dec 31, 2024